A clinical cohort observational study of esketamine in anesthesia for bronchoscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300067887

Enrollment

Unknown

Registered

2023-01-30

Start date

2023-02-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchoscopy

Interventions

Esketamine group:N/A

Non-esketamine group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with ASA grade I-II bronchoscopy aged 18-85 years.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients refused to be included in the group; 2. BMI greater than 28 kg/m2; 3. Patients with consciousness disorder can not cooperate; 4. Severe cardiopulmonary dysfunction; 5. Severe hypoxemia existed before surgery; 6. Severe abnormal liver and kidney function; 7. The treatment lasts more than 30 minutes.

Design outcomes

Primary

Measure	Time frame
Vital sign;	—

Secondary

Measure	Time frame
side effect;	—

Countries

China

Contacts

Public ContactCao Zhang

The Fourth Affiliated Hospital Zhejiang University School of Medicine

bioger@126.com+86 15858931168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026